Filing Details

Accession Number:
0001415889-24-016677
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-13 16:30:17
Reporting Period:
2024-06-12
Accepted Time:
2024-06-13 16:30:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2014286 Deyaa Adib C/O Fibrogen, Inc.
409 Illinois Street
San Francisco CA 94158
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-06-12 22,123 $1.17 82,123 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct